The High Court has decided to weigh in on whether computer-implemented inventions are eligible for patent protection, granting special leave to Aristocrat Technologies to challenge a judgment that shot down four patents for its popular Lightning Link electronic poker machine.
Technology company Nuix has been hit with a third shareholder class action over its troubled $1.8 billion float on the ASX, setting up what is likely to be the first beauty parade in the Supreme Court of Victoria since the state allowed class action lawyers to seek a cut of any settlement or judgment.
Buy now, pay later giant Zip Co cannot rely on its infringing use of the ‘Zip’ trade mark to defend a lawsuit by the mark’s owner Firstmac, the mortgage provider’s barrister told a judge on the first day of trial in the high-stakes intellectual property dispute.
The maker of Mother brand energy drinks has filed an appeal challenging a judge’s decision to remove two of its registered ‘Mother’ trade marks for non-use.
Telstra has been hit with a class action on behalf of employees who lost their jobs or are in danger of being terminated for failing to comply with a requirement that they be vaccinated against COVID-19.
Bayer says the patents office was wrong to quash an extension for its patent covering an oral contraceptive on the grounds that its application should have been based on a drug with an earlier approval date.
Labour hire firm CoreStaff will pay $6.4 million to settle a class action accusing it of using the promise of long-term work to lure workers to Australia from Papua New Guinea, only to terminate their employment agreements less than three years after they made the move.
The NSW Independent Commission Against Corruption has found Holding Redlich managing partner Ian Robertson’s account of a meeting where he allegedly advised the former NSW Labor general secretary to cover up a $100,000 illegal political donation “inconceivable”, but declined to refer the lawyer for criminal charges or disciplinary action.
Bristol-Myers Squibb unit Celgene has dropped a lawsuit accusing Indian generics company Dr Reddy’s Laboraties of threatening to infringe its patent for Revlimid with the planned launch of a generic version of the blockbuster cancer drug in Australia.
The High Court has shot down Greensill founder Lex Greensill’s bid for special leave to challenge a finding that he owes tax on $58 million in capital gains, including income from the sale of shares in the collapsed UK-based supply chain finance company.